Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
about
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionPrognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
P2860
Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@ast
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@en
type
label
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@ast
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@en
prefLabel
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@ast
Regulation of aldo-keto-reduct ...... t of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Regulation of aldo-keto-reduct ...... ct of hepatocellular carcinoma
@en
P2093
Chia-Chia Liu
Jun-Yang Liou
Shu-Man Liang
Shyh-Chang Chen
Tzu-An Liu
Yee-Jee Jan
P2860
P304
38967-38982
P356
10.18632/ONCOTARGET.5734
P407
P577
2015-11-01T00:00:00Z